“but I will have difficulty in grasping any reason they give for not continuing LL beyond trial close.”

This is why being a long shareholder of CYDY is so frustrating. It seems like a NO BRAINER to all of us to continue treating these mTNBC patients right? I mean how much would that really cost? There weren’t that many patients. Why the F wouldn’t they simply continue to treat them and lengthen their survival rate? Makes no sense .. but then again look at CYDY over the years and nothing surprises me. Keep expectations very low and possibly get surprised!